CLINICAL_TRIALS
trial_result
· 2021-09-21
Clinical Trial Update: Study of AMG 531 to Evaluate the Safety & Efficacy in Patients With Non-Hodgkin's Lymphoma [Phase 1, Phase 2]
Summary
Clinical trial update for AMG 531 evaluating safety and efficacy in patients with Non-Hodgkin's Lymphoma across Phase 1 and Phase 2.
Upgrade for the full analysis, importance score, and drug timeline.
Diseases / indications
Drugs mentioned
Snippet
Sponsor: M.D. Anderson Cancer Center | Conditions: Lymphoma | Phase 1, Phase 2 | Status: COMPLETED | Results posted: 2021-09-21